Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early monocyte response following local ablation in hepatocellular carcinoma.
Kimm MA, Kästle S, Stechele MMR, Öcal E, Richter L, Ümütlü MR, Schinner R, Öcal O, Salvermoser L, Alunni-Fabbroni M, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M. Kimm MA, et al. Among authors: alunni fabbroni m. Front Oncol. 2022 Oct 24;12:959987. doi: 10.3389/fonc.2022.959987. eCollection 2022. Front Oncol. 2022. PMID: 36353535 Free PMC article.
Prediction of Protumorigenic Effects after Image-Guided Radiofrequency Ablation of Hepatocellular Carcinoma Using Biomarkers.
Stechele M, Wildgruber M, Markezana A, Kästle S, Öcal E, Kimm MA, Alunni-Fabbroni M, Paldor M, Haixing L, Salvermoser L, Pech M, Powerski M, Galun E, Ricke J, Goldberg SN. Stechele M, et al. Among authors: alunni fabbroni m. J Vasc Interv Radiol. 2023 Sep;34(9):1528-1537.e1. doi: 10.1016/j.jvir.2022.11.024. Epub 2022 Nov 25. J Vasc Interv Radiol. 2023. PMID: 36442741
Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.
Kästle S, Stechele MR, Richter L, Schinner R, Öcal E, Alunni-Fabbroni M, De Toni E, Corradini S, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M, Kimm MA. Kästle S, et al. Among authors: alunni fabbroni m. J Cancer Res Clin Oncol. 2023 Sep;149(12):9777-9786. doi: 10.1007/s00432-023-04875-z. Epub 2023 May 29. J Cancer Res Clin Oncol. 2023. PMID: 37247078 Free PMC article.
Radiofrequency Ablation-Induced Tumor Growth Is Suppressed by MicroRNA-21 Inhibition in Murine Models of Intrahepatic Colorectal Carcinoma.
Salvermoser L, Goldberg SN, Laville F, Markezana A, Stechele M, Ahmed M, Wildgruber M, Kazmierczak PM, Alunni-Fabbroni M, Galun E, Ricke J, Paldor M. Salvermoser L, et al. Among authors: alunni fabbroni m. J Vasc Interv Radiol. 2023 Oct;34(10):1785-1793.e2. doi: 10.1016/j.jvir.2023.06.019. Epub 2023 Jun 20. J Vasc Interv Radiol. 2023. PMID: 37348786
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM. Stechele M, et al. Among authors: alunni fabbroni m. Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2. Radiat Oncol. 2023. PMID: 37507808 Free PMC article.
CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC.
Salvermoser L, Goldberg SN, Alunni-Fabbroni M, Kazmierczak PM, Gröper MN, Schäfer JN, Öcal E, Burkard T, Corradini S, Ben Khaled N, Petrera A, Wildgruber M, Ricke J, Stechele M. Salvermoser L, et al. Among authors: alunni fabbroni m. Transl Oncol. 2024 May;43:101919. doi: 10.1016/j.tranon.2024.101919. Epub 2024 Feb 23. Transl Oncol. 2024. PMID: 38401507 Free PMC article.
Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
Weber S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, Öcal E, Zitzelsberger H, Mayerle J, Malfertheiner P, Ricke J. Weber S, et al. Among authors: alunni fabbroni m. Dig Dis Sci. 2024 Jul;69(7):2488-2501. doi: 10.1007/s10620-024-08446-1. Epub 2024 Apr 23. Dig Dis Sci. 2024. PMID: 38652389 Free PMC article.
Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer.
Öcal E, Alunni-Fabbroni M, Piseddu I, Thaler M, Zacherl MJ, Salvermoser L, Stechele MMR, Burnell LF, Hirner-Eppeneder H, Kimm MA, Rudelius M, Seidensticker M, Wildgruber M, Goldberg SN, Ricke J. Öcal E, et al. Among authors: alunni fabbroni m. J Vasc Interv Radiol. 2024 Dec;35(12):1793-1805.e4. doi: 10.1016/j.jvir.2024.07.010. Epub 2024 Jul 22. J Vasc Interv Radiol. 2024. PMID: 39047935 Free article.
miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial.
Morkunas E, Vaitkeviciute E, Inciuraite R, Kupcinskas J, Link A, Skieceviciene J, Alunni-Fabbroni M, Schütte K, Malfertheiner P, Varkalaite G, Ricke J. Morkunas E, et al. Among authors: alunni fabbroni m. Dig Dis. 2024;42(4):336-348. doi: 10.1159/000538757. Epub 2024 Apr 24. Dig Dis. 2024. PMID: 38657585
Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.
Hirner-Eppeneder H, Öcal E, Stechele M, Öcal O, Gu S, Kimm MA, Wildgruber M, Salvermoser L, Kazmierczak P, Corradini S, Rudelius M, Piontek G, Pech M, Goldberg SN, Ricke J, Alunni-Fabbroni M. Hirner-Eppeneder H, et al. Among authors: alunni fabbroni m. J Cancer Res Clin Oncol. 2023 Nov;149(14):13017-13026. doi: 10.1007/s00432-023-05185-0. Epub 2023 Jul 19. J Cancer Res Clin Oncol. 2023. PMID: 37466799 Free PMC article.
55 results